Where is the live CopyMark page for USPTO serial 79270024?

The live record is at https://getcopymark.com/trademark/79270024. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns RAYBOW PHARMACEUTICAL?

According to the public USPTO record for serial number 79270024, the listed owner(s) include: Zhejiang Raybow Pharmaceutical Co., Ltd., Zhejiang Raybow Pharmaceutical Co., Ltd., Zhejiang Raybow Pharmaceutical Co., Ltd..

What is USPTO serial number 79270024?

Serial number 79270024 is the USPTO application identifier for the mark RAYBOW PHARMACEUTICAL. It is used to track examination, publication, and registration of this trademark.

What is the current status of RAYBOW PHARMACEUTICAL?

RAYBOW PHARMACEUTICAL (79270024) currently shows USPTO status code 739 on the public record. This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Which trademark classes cover RAYBOW PHARMACEUTICAL?

The public record lists International Classes: 005, 039, 042, 044. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: RAYBOW PHARMACEUTICAL Serial# 79270024 Reg# 6115538 | Section 8 declaration is in the USPTO grace period; file by Feb 4, 2027 | status 739; last event NA75 | Trademark Info & Attorney Guidance

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with RAYBOW PHARMACEUTICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Get help with this Renewal, set up monitoring, or talk with CopyMark.

Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Trademark Monitoring (312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gazal Pour-Moezzi

Gazal Pour-Moezzi Sheppard Mullin Richter & Hampton LLP650 Town Center Drive, 10th FloorCosta Mesa, CA 92626United States

Goods and services

Class	Description	Status	First use
005	Medical, pharmaceutical and veterinary preparations and substances, namely, for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders; as well as health care preparations, namely, pharmaceutical preparations for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders; medicines for the treatment of diseases associated with the central nervous system; hypoglycemic drugs; medicines for the treatment of antiviral disorders; medicines for the treatment of tumors; cardiovascular treatment preparations; nonsteroidal anti-inflammatory drugs; anti-infectives; chemical preparations for veterinary or pharmaceutical purposes, namely for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders	ACTIVE	—
039	Distribution of products in the field of pharmaceuticals, namely, transportation and delivery of health care preparations in the form of pharmaceutical products, including finished products and semi-finished products for veterinary and cosmetic purposes	ACTIVE	—
042	Pharmaceutical research for the discovery of new drugs; scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical or veterinary fields; research and development of new pharmaceutical preparations for others; scientific research in the field of pharmacy	ACTIVE	—
044	Medical services, veterinary services; medical consultancy in the field of healthcare and dispensing of pharmaceutical preparations and pharmaceutical consultancy in the field of healthcare and dispensing of pharmaceutical preparations, the aforesaid services also provided via electronic networks, including the internet	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Sep 23, 2026	NA75	NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED	—
Sep 23, 2026	C75A	REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.	—
Sep 20, 2026	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
Jul 30, 2026	ES75	TEAS SECTION 71 & 15 RECEIVED	—
Aug 4, 2025	REM3	COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED	—
Dec 12, 2020	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Nov 25, 2020	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Nov 25, 2020	FIMP	FINAL DISPOSITION PROCESSED	—
Nov 4, 2020	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Aug 4, 2020	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 19, 2020	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
May 19, 2020	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 29, 2020	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Apr 13, 2020	ALIE	ASSIGNED TO LIE	—
Apr 6, 2020	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Apr 4, 2020	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Apr 3, 2020	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Apr 3, 2020	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2019	RFNT	REFUSAL PROCESSED BY IB	—
Nov 19, 2019	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Nov 19, 2019	RFRR	REFUSAL PROCESSED BY MPU	—
Oct 29, 2019	MAFR	APPLICATION FILING RECEIPT MAILED	—
Oct 27, 2019	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Oct 26, 2019	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2019	DOCK	ASSIGNED TO EXAMINER	—
Oct 25, 2019	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Oct 24, 2019	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

RAYBOW PHARMACEUTICAL